|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3900 USD | -2.50% |
|
-2.50% | -13.33% |
| 04-06 | Zivo Bioscience Inc Signs Manufacturing Agreement with Cyanotech Corporation for Zivolife Algal Biomass | CI |
| 11-12 | Cyanotech Corporation, Q2 2026 Earnings Call, Nov 11, 2025 |
| Market Cap | 2.17M 1.9M 1.76M 1.64M 3.08M 205M 3.1M 20.84M 8.07M 101M 8.16M 7.99M 351M | P/E 2024 |
-0.36x | P/E 2025 | -0.77x |
|---|---|---|---|---|---|
| Enterprise Value | 13.48M 11.75M 10.89M 10.19M 19.11M 1.27B 19.23M 129M 50.05M 626M 50.61M 49.52M 2.17B | EV / Sales 2024 |
0.53x | EV / Sales 2025 | 0.57x |
| Free-Float |
67.86% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Cyanotech Corporation
| 1 day | -2.50% | ||
| 1 week | -2.50% | ||
| Current month | +5.41% | ||
| 1 month | -25.00% | ||
| 3 months | +25.40% | ||
| 6 months | +11.43% | ||
| Current year | -13.33% |
| 1 week | 0.39 |  | 0.39 |
| 1 month | 0.37 | | 0.52 |
| Current year | 0.23 | | 0.55 |
| 1 year | 0.21 | | 0.57 |
| 3 years | 0.12 | | 1.14 |
| 5 years | 0.12 | | 3.95 |
| 10 years | 0.12 | | 6.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew Custer
CEO | Chief Executive Officer | 43 | 16/06/2022 |
Gerald Cysewski
CEO | Chief Executive Officer | 77 | 31/03/2016 |
| Director of Finance/CFO | 46 | 21/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
David Mulder
BRD | Director/Board Member | 65 | 17/05/2016 |
David Vied
BRD | Director/Board Member | 65 | 27/01/2015 |
Matthew Custer
BRD | Director/Board Member | 43 | 16/06/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/09/25 | Free | Chief Financial Officer | 50,000 | 0.6987% | ||
| 28/08/25 | Free | Director | 50,000 | 0.6987% | ||
| 28/08/25 | Free | Director | 50,000 | 0.6987% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.50% | -2.50% | +10.80% | -63.89% | 2.83M | |
| -1.21% | -3.04% | +44.03% | +143.07% | 980B | |
| -2.48% | -5.18% | +52.47% | +39.15% | 550B | |
| -2.14% | -4.94% | +16.83% | +57.08% | 382B | |
| +0.25% | -3.09% | +23.33% | +16.04% | 316B | |
| +0.61% | -1.69% | +27.35% | +13.73% | 272B | |
| +0.22% | -3.10% | +24.67% | +30.49% | 268B | |
| +4.59% | +1.98% | -38.43% | -46.26% | 199B | |
| -1.19% | -4.95% | +16.68% | +47.69% | 182B | |
| -1.35% | -1.46% | +14.06% | +59.26% | 154B | |
| Average | -0.52% | -2.71% | +19.18% | +29.64% | 330.23B | |
| Weighted average by Cap. | -0.78% | -3.68% | +29.49% | +63.31% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 23.07M 20.12M 18.63M 17.44M 32.71M 2.18B 32.91M 221M 85.66M 1.07B 86.6M 84.74M 3.72B | 24.22M 21.11M 19.55M 18.31M 34.33M 2.28B 34.54M 232M 89.9M 1.12B 90.9M 88.95M 3.91B |
| Net income | -5.27M -4.59M -4.25M -3.98M -7.47M -497M -7.51M -50.46M -19.55M -245M -19.77M -19.35M -849M | -3.2M -2.79M -2.59M -2.42M -4.54M -302M -4.57M -30.68M -11.89M -149M -12.02M -11.77M -517M |
| Net Debt | 10.2M 8.89M 8.23M 7.71M 14.46M 962M 14.54M 97.68M 37.86M 474M 38.28M 37.46M 1.64B | 11.31M 9.86M 9.13M 8.55M 16.03M 1.07B 16.13M 108M 41.98M 525M 42.44M 41.53M 1.82B |
Employees
83
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/06/26 | 0.3900 $ | -2.50% | 125 |
- Stock Market
- Stocks
- CYAN Stock
Select your edition
All financial news and data tailored to specific country editions
